Liver-related aspects of gene therapy for haemophilia: Call to action for collaboration between haematologists and hepatologists

Affiliations

¹ Medical Clinic 2 / Institute of Transfusion Medicine and Immunohaematology, University Hospital Frankfurt, Germany. Electronic address: wolfgang.miesbach@kgu.de.
² Department of Hepatology, Queen Mary University of London, United Kingdom.
³ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy.

Wolfgang Miesbach et al. J Hepatol. 2023 Mar.

. 2023 Mar;78(3):467-470.

doi: 10.1016/j.jhep.2022.11.014. Epub 2022 Nov 25.

¹ Medical Clinic 2 / Institute of Transfusion Medicine and Immunohaematology, University Hospital Frankfurt, Germany. Electronic address: wolfgang.miesbach@kgu.de.
² Department of Hepatology, Queen Mary University of London, United Kingdom.
³ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy.

No abstract available

Comment in

Multidisciplinary approach and reactive immunosuppression for gene therapy-related hepatotoxicity.
Jagadisan B, Dhawan A. Jagadisan B, et al. J Hepatol. 2023 Aug;79(2):e67-e68. doi: 10.1016/j.jhep.2023.03.021. Epub 2023 Mar 28. J Hepatol. 2023. PMID: 36996939 No abstract available.
Multidisciplinary approach for gene therapy-related hepatotoxicity.
Jagadisan B, Dhawan A. Jagadisan B, et al. J Thromb Haemost. 2023 Jul;21(7):1998-1999. doi: 10.1016/j.jtha.2023.03.043. J Thromb Haemost. 2023. PMID: 37330267 No abstract available.